JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 11, 2005; DOI: 10.1124/jpet.105.088211


0022-3565/05/3151-42-50$20.00
JPET 315:42-50, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.088211v1
315/1/42    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mezentsev, A.
Right arrow Articles by Laniado-Schwartzman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mezentsev, A.
Right arrow Articles by Laniado-Schwartzman, M.

CELLULAR AND MOLECULAR

Transfection of Cytochrome P4504B1 into the Cornea Increases Angiogenic Activity of the Limbal Vessels

Alexandre Mezentsev, Vladimir Mastyugin, Francesca Seta, Silvia Ashkar, Rowena Kemp, D. Sudarshan Reddy, John R. Falck, Michael W. Dunn, and Michal Laniado-Schwartzman

Department of Pharmacology, New York Medical College, Valhalla, New York (A.M., V.M., F.S., S.A., R.K., M.W.D., M.L.-S.); and Departments of Biochemistry and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.S.R., J.R.F.)

Injury to the ocular surface induces the production of the corneal epithelial-derived 12-hydroxyeicosatetrienoic acid (12-HETrE), which exhibits stereospecific potent inflammatory and angiogenic properties and is formed by a cytochrome P450 (P450) enzyme, CYP4B1. We have cloned the rabbit corneal CYP4B1 into the expression plasmid pIRES2-enhanced green fluorescent protein (EGFP) and examined the effect of CYP4B1 overexpression on corneal inflammation in vivo and limbal vessel sprouting ex vivo. Cultured rabbit corneal epithelial cells transfected with pIRES2-EGFP-CYP4B1 metabolized arachidonic acid to 12-HETrE at a rate five times higher than that of pIRES2-EGFP-transfected cells (3.53 ± 0.08 versus 0.62 ± 0.10 nmol/h/106 cells; mean ± S.E.M., n = 6, p < 0.05), indicating a functional expression of the CYP4B1. Injection of either plasmid into the rabbit cornea resulted in EGFP fluorescence in the corneal epithelium. However, corneal neovascularization, as measured by the length of penetrating blood vessels, was significantly greater in the corneas of eyes transfected with the pIRES2-CYP4B1 compared with pIRES2-EGFP. Corneal-limbal explants from eyes transfected with pIRES2-CYP4B1 showed a marked angiogenic activity (46 ± 10 versus 12 ± 3 mm capillary length, n = 6, p < 0.05), which correlated with increased levels of 12-HETrE, the CYP4B1-derived angiogenic 12-hydroxyeicosanoid (0.93 ± 0.18 versus 0.15 ± 0.02 pmol/explant, n = 6, p < 0.05), and was inhibited (76 ± 5%) by the P450 inhibitor 17-octadecynoic acid. The results further implicate the corneal CYP4B1 as a component of the inflammatory and angiogenic cascade initiated by injury to the ocular surface and raise the possibility of a new therapeutic target for preventing corneal neovascularization, namely, the CYP4B1-12-HETrE system.


Received April 19, 2005; accepted June 29, 2005.

Address correspondence to: Dr. Michal Laniado Schwartzman, Department of Pharmacology, New York Medical College, Valhalla, NY 10595. E-mail: michal_schwartzman{at}nymc.edu




This article has been cited by other articles:


Home page
IOVSHome page
K. Patil, L. Bellner, G. Cullaro, K. H. Gotlinger, M. W. Dunn, and M. L. Schwartzman
Heme Oxygenase-1 Induction Attenuates Corneal Inflammation and Accelerates Wound Healing after Epithelial Injury
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3379 - 3386.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Seta, L. Bellner, R. Rezzani, R. F. Regan, M. W. Dunn, N. G. Abraham, K. Gronert, and M. Laniado-Schwartzman
Heme Oxygenase-2 Is a Critical Determinant for Execution of an Acute Inflammatory and Reparative Response
Am. J. Pathol., November 1, 2006; 169(5): 1612 - 1623.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.